Join to view full profile
55 Fruit St Fl 8Boston, MA 02114
Phone+1 617-724-3914
Dr. Berry is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2006 - 2009
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2005 - 2006
Northwestern University The Feinberg School of MedicineClass of 2005
Certifications & Licensure
MA State Medical License 2009 - 2027
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Emergencies in Amyotrophic Lateral Sclerosis.S Pinar Uysal, Katherine A Dudley, Stacey Sullivan, Kate T Brizzi, Katherine M Burke
Muscle & Nerve. 2026-12-01 - At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial.Eric A Macklin, James D Berry, Brittney A Harkey, Lindsay Heyd, Marianne Chase
Muscle & Nerve. 2026-09-01 - DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.Sabrina Paganoni, Lori B Chibnik, Melanie Quintana, Eric A Macklin, Michelle A Detry
JAMA Network Open. 2026-09-01
Press Mentions
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch ProgramNovember 25th, 2025- The ALL ALS Consortium’s Open Science InitiativeMay 27th, 2025
- ALL ALS Consortium Creates a Central Information Hub to Accelerate ALS ResearchMarch 30th, 2025
Grant Support
- Clinical and Usability Validation of Gait Velocity (SV95C) Measured from Wearable Digital SensorsMASSACHUSETTS GENERAL HOSPITAL2026–2028
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2028
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2028
- An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with PridopidineMASSACHUSETTS GENERAL HOSPITAL2023–2027
- A diagnostic biomarker for amyotrophic lateral sclerosisJOHNS HOPKINS UNIVERSITY2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: